Skip to main content
Caplight Logo









HNL Lab Medicine

HNL Lab Medicine

Private
Allentown, PennsylvaniaHealthcare & Life Scienceshttps://www.hnl.com/

Last Round

M&A

Aug 1, 2024

Company Overview

HNL Lab Medicine is a healthcare company that provides full-service medical laboratory testing and diagnostic services to hospitals, physician offices, and long-term care facilities.

Sector

Healthcare & Life Sciences

Verticals

Healthcare Analytics, Precision Medicine, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

clinical laboratorypathology servicesdiagnostic testingreference laboratorylaboratory managementmolecular diagnosticselectronic health recordEHRoccupational healthdigital pathologylab outreachlab-as-a-servicehospital lab partnercytogeneticsdiagnostic analytics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

HNL Lab Medicine Comparables

Compare HNL Lab Medicine with similar companies based on industry and business-model similarity.

No public comparables are available for HNL Lab Medicine. Request access to learn about comparables coverage.

Request access

HNL Lab Medicine Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
M&AAug 1, 2024
M&AJan 15, 2019

Key People

Founding team and executive leadership

Martin K. Till

President & CEO

Executive Team

Matthew Sorrentino

Chief Executive Officer

Executive Team

Warren W Erdmann

Chief Operating Officer

Executive Team

HNL Lab Medicine Investors

Notable investors and investment history

HNL Lab Medicine investors
InvestorRounds
Jefferson HealthM&A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 1, 2024

    Led by Jefferson Health

HNL Lab Medicine Filings

Explore SEC and related filing metadata, where available.

HNL Lab Medicine filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about HNL Lab Medicine's valuation, stock price, and market status.

Is HNL Lab Medicine a public or private company?

HNL Lab Medicine is a private company.

What is the current stock price of HNL Lab Medicine?

HNL Lab Medicine is a private company with no public stock price. Caplight tracks HNL Lab Medicine's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is HNL Lab Medicine worth (valuation)?

Valuation information for HNL Lab Medicine is not publicly available.

Can I buy HNL Lab Medicine stock?

HNL Lab Medicine shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was HNL Lab Medicine's last funding round?

HNL Lab Medicine's most recent funding round was M&A on August 1, 2024.

Who are the main investors in HNL Lab Medicine?

Key investors in HNL Lab Medicine include Jefferson Health.

Will HNL Lab Medicine IPO soon?

No public IPO plans have been announced for HNL Lab Medicine.

How can I track HNL Lab Medicine secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor HNL Lab Medicine's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersAllentown, Pennsylvania
Employee Range678
Year Founded1998
Last FundingAug 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?